Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Teiko Bio is a precision medicine company specializing in high-dimensional immune profiling to accelerate drug development and improve patient outcomes. Utilizing advanced mass cytometry (CyTOF) technology, the company provides comprehensive immune monitoring services for clinical trials, helping biopharmaceutical partners identify biomarkers of response and resistance. Their proprietary platform, Toku, enables the mapping of the immune system at single-cell resolution, facilitating better patient stratification and therapeutic selection. Teiko Bio focuses primarily on oncology, immunology, and infectious diseases, bridging the gap between complex biological data and actionable clinical insights.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Teiko Bio.